4//SEC Filing
Wilson Alexander Blair 4
Accession 0001104659-24-097066
CIK 0001837607other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 9:58 PM ET
Size
8.1 KB
Accession
0001104659-24-097066
Insider Transaction Report
Form 4
Wilson Alexander Blair
Exec VP, CLO & Corp Secretary
Transactions
- Award
Class A Common Stock
2024-08-31+180,110→ 261,538 total - Award
Stock Option
2024-08-31+480,631→ 480,631 totalExercise: $0.83Exp: 2034-08-30→ Class A Common Stock (480,631 underlying)
Footnotes (3)
- [F1]Represents an award of restricted stock units granted on August 31, 2024 (the "Grant Date"), which vests in full on the second anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date.
- [F2]Includes an award of restricted stock units ("RSUs") in the amount of 81,428 previously granted on April 26, 2023, which were previously reported on July 24, 2023 as derivative securities in Table II due to a clerical error, and which are now being reported as common stock in Table I. The vesting terms for the RSUs have not changed from what was previously reported on July 24, 2023.
- [F3]Represents an award of stock options granted on August 31, 2024 (the "Grant Date"), which vest and become exercisable in substantially equal monthly installments over the eighteen months following the Grant Date, subject to the reporting person's continued service through the applicable vesting date.
Documents
Issuer
AEON Biopharma, Inc.
CIK 0001837607
Entity typeother
Related Parties
1- filerCIK 0001979602
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 9:58 PM ET
- Size
- 8.1 KB